Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

TAVR still a safe treatment option for immunocompromised patients
While patients with a weakened immune system are still more likely to die after TAVR than other patients, those deaths are largely not related to the procedure or any other cardiovascular issues. This new meta-analysis explored data from a variety of clinical trials.
Pope welcomes cardiologists to Vatican City
Pope Leo XIV told interventional cardiologists their work “stands at the crossroads of science, compassion and ethical responsibility.” When they treat patients, he added, they are treating the heart “both physically and metaphorically, bringing relief to those who suffer.”
Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR
The company expects TAVR sales alone to be as high as $4.9 billion in 2026. Other minimally invasive therapies are projected to make a major impact as well.
FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public
The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.
Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.

FDA grants breakthrough therapy designation to new drug candidate for FA cardiomyopathy

The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.

Low-intensity focused ultrasound a noninvasive treatment option for lingering COVID symptoms

New research suggests the technique can effectively break down amyloid fibrinogen microclots, which are believed to interfere with perfusion and cause inflammation.

Congress Money washington DC legislation coverage payment

With MPFS proposal on the way, electrophysiology groups outline their priorities

The Heart Rhythm Society and its new advocacy arm plan on pushing CMS to include certain policy improvements in the 2026 MPFS.

U.S. Department of Health and Human Services (HHS) sign.

HHS, RFK sued by medical associations over COVID policy shift

Multiple professional groups, including the American Academy of Pediatrics and the American College of Physicians, challenge recent policy changes to vaccine recommendations for COVID-19, which end routine inoculations for minors and pregnant women.

New TAVR valve from MiRus linked to positive early outcomes

The Siegel TAVR valve includes no nickel or cobalt. In fact, its frame was built using special alloys specifically developed by MiRus.

heart data research doctor cardiologist AI

EHR-driven PCI risk assessments could make a world of difference

Researchers with Mayo Clinic have shown that EHR-driven risk assessments could go a long way toward improving care for PCI patients.

Farapulse Boston Scientific Pulsed Field Ablation PFA fda approval

FDA expands approval of Boston Scientific’s Farapulse PFA system

The FDA's 2024 approval of the Farapulse system covered patients with paroxysmal atrial fibrillation. Now, however, the technology is officially approved for patients with more persistent symptoms.

No biopsy required: Blood test could spot signs of rejection in heart transplant recipients

It may not always be necessary to subject heart transplant patients to one biopsy after another.

Clinical

TAVR still a safe treatment option for immunocompromised patients

Pope welcomes cardiologists to Vatican City

Edwards Lifesciences shares positive outlook for 2026, pointing to continued importance of TAVR

FDA commissioner claims Biden administration hid heart risks of COVID-19 vaccines from public

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M